Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Cross-neutralizing Monoclonal Antibodies Against Respiratory Viruses
From the Boonyaratanakornkit, Taylor and Pancera labs, Vaccine and Infectious Disease Division and Cancer Immunology Program, Cancer Consortium
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function
Summaries of recent Fred Hutch research findings and other news
Hutch researchers discover neutralizing antibodies to parainfluenza
New hope for transplant patients vulnerable to this common respiratory virus
Antibodies a hot topic in COVID-19 research
Hutch scientists tap their antibody expertise for new tests, treatments, vaccines
Pushing science forward while working from home
As COVID-19 forces research labs to drastically reduce on-site operations, scientists figure out how to advance their work and stay connected
Your vote needed! Hutch science competes in 'STAT Madness'
Studies by Drs. Justin Taylor, Robert Bradley are finalists in annual competition for best biomedical advance
Fine-tuning B cell responses
From the Taylor Lab, Vaccine and Infectious Disease Division
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
Baiting for B cells: A clever new way to make an AIDS vaccine
Researchers fish for rare blood cells that can evolve into HIV blockers
Creating antibodies with antibodies
From the McGuire, Taylor, and Stamatatos labs, Vaccine and Infectious Disease Division
‘Community coming together’: Obliteride raises more than $2.5M for cancer research
Record number of participants register to ride, walk and run for science at Fred Hutch
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
First test of 'off-the-shelf' cord blood cell product outside the transplantation setting
Celebrating faculty and staff achievements
Growing a lab: How a young scientist makes leap from postdoc to principal investigator
A young scientist makes the leap from postdoc to principal investigator
Catching up with the flu
Fred Hutch research sheds light on why we need yearly flu shots and suggests the possibility of a single, lifetime vaccine